These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7852321)

  • 21. Distinct physical and structural properties of the ovine uterine serpin.
    Peltier MR; Grant TR; Hansen PJ
    Biochim Biophys Acta; 2000 Jun; 1479(1-2):37-51. PubMed ID: 11004528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional structure and molecular modelling of C1- inhibitor.
    Perkins SJ
    Behring Inst Mitt; 1993 Dec; (93):63-80. PubMed ID: 8172587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema.
    Davis AE; Bissler JJ; Cicardi M
    Behring Inst Mitt; 1993 Dec; (93):313-20. PubMed ID: 8172583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The native metastable fold of C1-inhibitor is stabilized by disulfide bonds.
    Simonovic I; Patston PA
    Biochim Biophys Acta; 2000 Aug; 1481(1):97-102. PubMed ID: 11004579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conformational changes in serpins and the mechanism of alpha 1-antitrypsin deficiency.
    Carrell RW; Whisstock J; Lomas DA
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S171-5. PubMed ID: 7952655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of serpin action: evidence that C1 inhibitor functions as a suicide substrate.
    Patston PA; Gettins P; Beechem J; Schapira M
    Biochemistry; 1991 Sep; 30(36):8876-82. PubMed ID: 1888745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas.
    Aulak KS; Harrison RS
    Biochem J; 1990 Nov; 271(3):565-9. PubMed ID: 2244865
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partitioning of serpin-proteinase reactions between stable inhibition and substrate cleavage is regulated by the rate of serpin reactive center loop insertion into beta-sheet A.
    Lawrence DA; Olson ST; Muhammad S; Day DE; Kvassman JO; Ginsburg D; Shore JD
    J Biol Chem; 2000 Feb; 275(8):5839-44. PubMed ID: 10681574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crystal structure of an uncleaved serpin reveals the conformation of an inhibitory reactive loop.
    Wei A; Rubin H; Cooperman BS; Christianson DW
    Nat Struct Biol; 1994 Apr; 1(4):251-8. PubMed ID: 7656054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The inhibition mechanism of serpins. Evidence that the mobile reactive center loop is cleaved in the native protease-inhibitor complex.
    Wilczynska M; Fa M; Ohlsson PI; Ny T
    J Biol Chem; 1995 Dec; 270(50):29652-5. PubMed ID: 8530349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of latent alpha 1-antitrypsin.
    Lomas DA; Elliott PR; Chang WS; Wardell MR; Carrell RW
    J Biol Chem; 1995 Mar; 270(10):5282-8. PubMed ID: 7890640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism.
    Egelund R; Petersen TE; Andreasen PA
    Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the P2 residue in determining the specificity of serpins.
    Djie MZ; Le Bonniec BF; Hopkins PC; Hipler K; Stone SR
    Biochemistry; 1996 Sep; 35(35):11461-9. PubMed ID: 8784202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serpin conformational change in ovalbumin. Enhanced reactive center loop insertion through hinge region mutations.
    Huntington JA; Fan B; Karlsson KE; Deinum J; Lawrence DA; Gettins PG
    Biochemistry; 1997 May; 36(18):5432-40. PubMed ID: 9154925
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The structure of a Michaelis serpin-protease complex.
    Ye S; Cech AL; Belmares R; Bergstrom RC; Tong Y; Corey DR; Kanost MR; Goldsmith EJ
    Nat Struct Biol; 2001 Nov; 8(11):979-83. PubMed ID: 11685246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of strand 1 of the C beta-sheet in the structure and function of alpha(1)-antitrypsin.
    Bottomley SP; Lawrenson ID; Tew D; Dai W; Whisstock JC; Pike RN
    Protein Sci; 2001 Dec; 10(12):2518-24. PubMed ID: 11714919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a new P1 residue mutation (444Arg----Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma.
    Aulak KS; Cicardi M; Harrison RA
    FEBS Lett; 1990 Jun; 266(1-2):13-6. PubMed ID: 2365061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reactive Center Loop Insertion in α-1-Antitrypsin Captured by Accelerated Molecular Dynamics Simulation.
    Andersen OJ; Risør MW; Poulsen EC; Nielsen NC; Miao Y; Enghild JJ; Schiøtt B
    Biochemistry; 2017 Jan; 56(4):634-646. PubMed ID: 27995800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema.
    Ocejo-Vinyals JG; Leyva-Cobián F; Fernández-Luna JL
    Mol Med; 1995 Sep; 1(6):700-5. PubMed ID: 8529136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.